More specifically, previous studies have shown that downregulating the Wnt pathway by transfecting Dkk-3 and dominant-negative LRP5 into osteosarcoma cells significantly reduced invasion capacity and cell motility potentially by recruiting β-catenin to the cell surface to promote cell-cell adhesion [20]. The gene discussed is LRP5; the disease is osteosarcoma.